Reuters

Insight: Evidence grows for narcolepsy link to GSK swine flu shot

Share Slideshow

Emelie Olsson falls asleep as she watches television in her apartment in Stockholm, January 17, 2013. Emelie is one of around 800 children in Sweden and elsewhere in Europe who developed narcolepsy, an incurable sleep disorder, after being immunised in 2009 with the Pandemrix H1N1 swine flu vaccine made by British drugmaker GlaxoSmithKline. Picture taken January 17, 2013. REUTERS/Ints Kalnins

Emelie Olsson falls asleep as she watches television in her apartment in Stockholm, January 17, 2013. Emelie is one of around 800 children in Sweden and elsewhere in Europe who developed narcolepsy, an incurable sleep disorder, after being immunised in 2009 with the Pandemrix H1N1 swine flu vaccine made by British drugmaker GlaxoSmithKline. Picture taken January 17, 2013. REUTERS/Ints Kalnins
Close
1 / 13

Emelie Olsson shows her paintings in Stockholm January 17, 2013. REUTERS/Ints Kalnins

Emelie Olsson shows her paintings in Stockholm January 17, 2013. REUTERS/Ints Kalnins
Close
2 / 13

Emelie Olsson practices during a dance lesson in Stockholm January 19, 2013.REUTERS/Ints Kalnins

Emelie Olsson practices during a dance lesson in Stockholm January 19, 2013.REUTERS/Ints Kalnins
Close
3 / 13

Emelie Olsson (R), her brother Andreas (L), father Charles (top L) and mother Marie eat dinner in Stockholm January 19, 2013. REUTERS/Ints Kalnins

Emelie Olsson (R), her brother Andreas (L), father Charles (top L) and mother Marie eat dinner in Stockholm January 19, 2013. REUTERS/Ints Kalnins
Close
4 / 13

Emelie Olsson applies her makeup in Stockholm January 19, 2013. REUTERS/Ints Kalnins

Emelie Olsson applies her makeup in Stockholm January 19, 2013. REUTERS/Ints Kalnins
Close
5 / 13

Emelie Olsson (R) and her mother Marie play with rabbit Stampe in Stockholm January 19, 2013. REUTERS/Ints Kalnins

Emelie Olsson (R) and her mother Marie play with rabbit Stampe in Stockholm January 19, 2013. REUTERS/Ints Kalnins
Close
6 / 13

Emelie Olsson watches television in Stockholm January 19, 2013. REUTERS/Ints Kalnins

Emelie Olsson watches television in Stockholm January 19, 2013. REUTERS/Ints Kalnins
Close
7 / 13

Emelie Olsson falls asleep as she watches television in Stockholm January 19, 2013. VACCINE/PANDEMRIX. REUTERS/Ints Kalnins

Emelie Olsson falls asleep as she watches television in Stockholm January 19, 2013. VACCINE/PANDEMRIX. REUTERS/Ints Kalnins
Close
8 / 13
Advertisement
Skip ad
3

Emelie Olsson sleeps during daytime in Stockholm January 20, 2013. REUTERS/Ints Kalnins

Emelie Olsson sleeps during daytime in Stockholm January 20, 2013. REUTERS/Ints Kalnins
Close
9 / 13

Emelie Olsson (R) her mother Marie (L) and her father Charles sit in their living room in Stockholm January 17, 2013. REUTERS/Ints Kalnins

Emelie Olsson (R) her mother Marie (L) and her father Charles sit in their living room in Stockholm January 17, 2013. REUTERS/Ints Kalnins
Close
10 / 13

Director for health and social care at the Swedish Association of Local Authorities and Regions Goran Stiernstedt gestures during an interview with Reuters in Stockholm January 17, 2013. Stiernstedt has spent many difficult hours going over what happened in his country during the swine flu pandemic, wondering if things should have been different. Finland, Norway, Ireland and France have seen spikes in narcolepsy cases in around 800...more

Director for health and social care at the Swedish Association of Local Authorities and Regions Goran Stiernstedt gestures during an interview with Reuters in Stockholm January 17, 2013. Stiernstedt has spent many difficult hours going over what happened in his country during the swine flu pandemic, wondering if things should have been different. Finland, Norway, Ireland and France have seen spikes in narcolepsy cases in around 800 children after being immunised with the Pandemrix H1N1 swine flu vaccine made by British drugmaker GlaxoSmithKline in 2009 and people familiar with the results of a soon-to-be-published study in Britain have told Reuters it will show a similar pattern in children there. Picture taken January 17, 2013.VACCINE/PANDEMRIX. REUTERS/Ints Kalnins
Close
11 / 13

The first shipment of pandemic vaccine against the swine influenza A (H1N1) Pandemrix arrives in Malmo in this October 9, 2009 file photo. Europe's drugs regulator has ruled Pandemrix should no longer be used in people aged under 20. The chief medical officer at GSK's vaccines division, Norman Begg, says his firm views the issue extremely seriously and is "absolutely committed to getting to the bottom of this", but adds there is...more

The first shipment of pandemic vaccine against the swine influenza A (H1N1) Pandemrix arrives in Malmo in this October 9, 2009 file photo. Europe's drugs regulator has ruled Pandemrix should no longer be used in people aged under 20. The chief medical officer at GSK's vaccines division, Norman Begg, says his firm views the issue extremely seriously and is "absolutely committed to getting to the bottom of this", but adds there is not yet enough data or evidence to suggest a causal link. REUTERS/Scanpix
Close
12 / 13

The first shipment of pandemic vaccine against the swine influenza A (H1N1) Pandemrix arrives in Malmo in this October 9, 2009 file photo. REUTERS/Scanpix

The first shipment of pandemic vaccine against the swine influenza A (H1N1) Pandemrix arrives in Malmo in this October 9, 2009 file photo. REUTERS/Scanpix
Close
13 / 13

All Collections

The stories of 2014

Wednesday, December 24, 2014

All Collections

End of a coal mine

Tuesday, December 23, 2014

All Collections

Siege of Sinjar broken

Tuesday, December 23, 2014

All Collections

Pictures of the year: Odd

Tuesday, December 23, 2014

All Collections

Embedded in Afghanistan

Tuesday, December 23, 2014

All Collections

Tsunami's unclaimed possessions

Tuesday, December 23, 2014

All Collections

The Syrian front

Monday, December 22, 2014

All Collections

The year in concert

Monday, December 22, 2014